EFFECT OF OZANIMOD TREATMENT AND DISCONTINUATION ON ABSOLUTE LYMPHOCYTE COUNT IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM A PHASE 3 RANDOMIZED TRIAL

Geert R. D'Haens  1     Peter Irving  2     Jean-Frédéric Colombel  3     AnnKatrin Petersen  4     Denesh Chitkara  4     Cecilia Marta  4     Tianlei Chen  4     Lorna Charles  4     Silvio Danese  5     Subrata Ghosh  6    
1 Amsterdam University Medical Centers, Amsterdam, Netherlands
2 IBD Centre, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
3 Icahn School of Medicine at Mount Sinai, New York, United States
4 Bristol Myers Squibb Company, Princeton, United States
5 Inflammatory Bowel Diseases Center, Humanitas Clinical and Research Center IRCCS and Hunimed, Milan, Italy
6 APC Microbiome Ireland, College of Medicine and Health, University College Cork, Cork, Ireland

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing